Top Versus Top: Progenics Pharmaceuticals Inc. (NASDAQ:PGNX), BlackRock, Inc. (NYSE:BLK)

Progenics Pharmaceuticals Inc. (NASDAQ:PGNX)

BlackRock, Inc. (NYSE:BLK)

BlackRock, Inc. (NYSE:BLK) closed at $614.53 on the last trading session with an decrease of -1.23%, whereas, it previously closed at $622.19. The company has a market capitalization of $93.4 Billion. The company traded shares of 349823 on the trading day while its three month average volume stands at 614.25 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of BlackRock, Inc. (NYSE:BLK) produced diluted EPS of 28.4. The EPS estimate for next year as estimated by analysts is at 34.6 while EPS for next quarter is estimated at 8.4. Earnings per Share growth for this year is reported at 6.9, while the analysts estimated the EPS growth for next year at 34.6% and Earnings growth for next 5 years stands at 9.92% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 8.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of BlackRock, Inc. (NYSE:BLK) is at 21.64 while the forward p/e is at 17.76. The P/S or Price to Sales ratio of BlackRock, Inc. (NYSE:BLK) stands at 6.22 and Price to Book or P/B for the most recent quarter stands at 2.89. The Price to Free Cash Flow ratio or P/FCF is reported at 175.57. The quick ratio and the current ratio of BlackRock, Inc. (NYSE:BLK) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for BlackRock, Inc. (NYSE:BLK) stands at 2.8, 13.5 and 11.1 respectively

The trailing twelve month Revenue of BlackRock, Inc. (NYSE:BLK) is reported at 15.03 Billion with income of 4.44 Billion. The outstanding shares of BlackRock, Inc. (NYSE:BLK) are 153.73 Million. The institutional Ownership of the shares of 88 stands at 0.80%, this figure is increased 0.67 in the last six months. The insider ownership for the shares of BlackRock, Inc. (NYSE:BLK) is ticked at 1.5%, the figure is plummeted -93.78% in the last six months.

Some other important financial aspects to be discussed here for BlackRock, Inc. (NYSE:BLK) is the Mean Target Price estimated by the analysts which stands at 707.47. The 52 week high of BlackRock, Inc. (NYSE:BLK) is placed at 666.64 and 52 week low is standing at 323.98.

Performance wise the shares of BlackRock, Inc. (NYSE:BLK) fell down -4.73% for the week, it also rise 10% for the monthly performance, while for the quarter it went down 6.39%. The shares increase 20.17% for the half year and flew up for the Year-To-Date performance. The shares of BlackRock, Inc. (NYSE:BLK) grew 31.72% for the yearly performance.